Dr. Krychman on Treating Cancer-Related Sexual Issues
Michael L. Krychman, MD, Executive Director of the Southern California Center for Sexual Health and Survivorship Medicine, discusses managing and treating sexual health concerns in cancer patients and survivors.
Karen Masino on Building a Survivorship Program
Karen Masino, from Ingalls Memorial Hospital, discusses the intricacies of developing a survivorship program.
Rajni Kannan on the Side Effects of Yervoy and Zelboraf
Rajni Kannan discusses the importance patient education or managing the side effects associated ipilimumab and vemurafenib in metastatic melanoma.
Photos From the 2012 NCONN Conference
Photos from the 2012 National Coalition of Oncology Nurse Navigators' (NCONN) annual conference that was held at the Gaylord Opryland Hotel from October 4th to 6th, in Nashville, Tennessee.
New Metastatic Melanoma Therapies Create Hope for Patients, Key Role for Oncology Nurses
The incidence of melanoma, the deadliest of all skin cancers, is quickly rising, and the disease is responsible for more than 8000 deaths each year.
Opportunity Knocks: New ACoS Standard Requires Navigation Process in Place by 2015
Facilities seeking Commission on Cancer accreditation now need to have a patient navigation process in place by 2015.
Beth DuPree, MD, Updates Navigators on Breast Cancer Treatments
Updates on breast cancer risk factors, screening methods, and treatments for the nurse navigators who are guiding patients from diagnosis to treatment and, hopefully, through survivorship.
Cristi Radford on the Nurse Navigator's Role in Genetic Counseling
Cristi Radford, a Certified Genetic Counselor, explains the multifaceted role that oncology nurse navigators play in the genetic counseling process.
Coverage From the 2012 NCONN Conference
OncLive presents live coverage from the 2012 NCONN Changing the Face of Cancer Care Conference, held at the Gaylord Opryland Hotel from October 4th to 6th, in Nashville, TN.
Later-Line Ruxolitinib Use Produces Ongoing Benefit in Real-World Patients With cGVHD
Orca-T Data With Survival, Tolerability Extends to Older Patients With Hematologic Cancers
Dr Ramdial on Gemcitabine/Clofarabine/Busulfan for Lymphoma Stem Cell Transplant
Retrospective Analysis Shows Post-HCT Survival Benefits With Orca-T Vs PTCy in Hematologic Malignancies
2 Commerce Drive Cranbury, NJ 08512